Results 251 to 260 of about 106,748 (296)
Some of the next articles are maybe not open access.
Blood, 2008
To the editor: The FMC7 antibody, originally described in 1981,[1][1] detects an antigen expressed on mature human B cells and is used in immunophenotypic analysis and differential diagnosis of lymphomas and leukemias. The identity of the FMC7 antigen was unclear for many years.
Julie P, Deans, Maria J, Polyak
openaire +2 more sources
To the editor: The FMC7 antibody, originally described in 1981,[1][1] detects an antigen expressed on mature human B cells and is used in immunophenotypic analysis and differential diagnosis of lymphomas and leukemias. The identity of the FMC7 antigen was unclear for many years.
Julie P, Deans, Maria J, Polyak
openaire +2 more sources
Inhibitory FcγRIIb and CD20 internalization
Blood, 2014In this issue of Blood, Vaughan et al demonstrate that certain antibodies that are used therapeutically in lymphoma treatment (e.g., rituximab) undergo Fcg receptor IIb (FcgRIIb)–mediated internalization from the B-cell surface in a manner that is independent of activation of FcgRIIb with important implications for the design of antibody-based ...
openaire +2 more sources
P138 Modulation of CD20 expression on B cells by anti-CD20 antibodies
Human Immunology, 2016Abstract The purpose of this communication is to describe a case that illustrates the interference of in vivo anti-CD20 treatment on B cell crossmatch (B-XM) results. A first kidney transplant candidate, female, white, 31 years-old, with systemic lupus erythematosus, without previous pregnancies, with one blood transfusion more than 15 years ago ...
Elaine C. Bellintani +6 more
openaire +1 more source
CD20 as a gatekeeper of the resting state of human B cells
Proceedings of the National Academy of Sciences of the United States of America, 2021Michael Reth +2 more
exaly
CD20+ T cells: an emerging T cell subset in human pathology
Inflammation Research, 2022Adrian Y. S. Lee
exaly
Proceedings of the National Academy of Sciences of the United States of America, 2023
Fredrik Piehl +2 more
exaly
Fredrik Piehl +2 more
exaly
International MS journal, 2008
Immune modulators, such as interferon beta and glatiramer acetate, have focused on T-cells as the primary therapeutic target, although both drugs affect other cell types as well. There has been a renewed interest in the potential roles of both antibody-dependent and antibody-independent B-cell responses in multiple sclerosis (MS) and its animal model ...
openaire +1 more source
Immune modulators, such as interferon beta and glatiramer acetate, have focused on T-cells as the primary therapeutic target, although both drugs affect other cell types as well. There has been a renewed interest in the potential roles of both antibody-dependent and antibody-independent B-cell responses in multiple sclerosis (MS) and its animal model ...
openaire +1 more source
Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies Free
Blood, 1998Jeffrey A Ledbetter
exaly